| Literature DB >> 36104691 |
Chang-Hao Zhong1, Zhu-Quan Su1, Wei-Zhan Luo1, Wan-Yuan Rao1, Jia-Xin Feng1, Chun-Li Tang1, Yu Chen1, Xiao-Bo Chen1, Ming-Yue Fan1, Shi-Yue Li2.
Abstract
BACKGROUND: A feasible and economical bronchoscopic navigation method in guiding peripheral pulmonary nodule biopsy is lacking.Entities:
Keywords: Bronchoscopy; Diagnostic yield; Hand-drawn bronchoscopic navigation; Peripheral pulmonary nodule; Virtual bronchoscopic navigation
Mesh:
Year: 2022 PMID: 36104691 PMCID: PMC9472376 DOI: 10.1186/s12931-022-02160-0
Source DB: PubMed Journal: Respir Res ISSN: 1465-9921
Fig. 1Bronchoscopy, CT image and navigation mapping of the right lung
Fig. 2Bronchoscopy, CT image and navigation mapping of the left lung
Fig. 3A case of patient with pulmonary nodule, the chest CT showed the lesion located in LB3bi. The chest CT slide was rotated by 90-degree clockwise (A), and the pathway to the target lung lesion was planned based upon the CT image (B). The opening of the left upper lobe assessed by bronchoscopy was in accordance with the rotated CT image (A and C). A radial ultrasound probe (D), biopsy forceps (E) and specimen brush (F) were respectively implemented for accurate positioning and tranbronchoscopic lung biopsy. The histopathological finding suggested pulmonary adenocarcinoma (G)
Demographic Characteristics
| VBN group | HBN group | ||
|---|---|---|---|
| Cases, No | 42 | 48 | |
| Age, median (IQR), y | 59.62 (30–85) | 56.75 (29–83) | 0.53 |
| Gender Male, No. (%) | 23 (54.76%) | 34 (70.83%) | 0.11 |
| Current smoker, No. (%) | 25 (59.52%) | 32 (66.67%) | 0.48 |
| Comorbidity | |||
| Hypertension, No. (%) | 17 (40.48%) | 23 (47.92%) | 0.48 |
| Coronary artery disease, No. (%) | 2 (4.76%) | 4 (8.33%) | 0.50 |
| Congestive heart failure, No. (%) | 3 (7.14%) | 5 (10.42%) | 0.59 |
| COPD, No. (%) | 8 (19.05%) | 12 (25.00%) | 0.50 |
HBN hand-drawn bronchoscopic navigation, VBN virtual bronchoscopic navigation, COPD chronic obstructive pulmonary disease
Comparison of bronchoscopic procedure between two groups
| VBN group | HBN group | ||
|---|---|---|---|
| Lobe# | |||
| Right upper lobe, No. (%) | 10 (23.81%) | 10 (20.83%) | 0.17 |
| Right middle lobe, No. (%) | 10 (23.81%) | 4 (8.4%) | |
| Right upper lobe, No. (%) | 10 (23.81%) | 18 (37.50%) | |
| Left upper lobe, No. (%) | 2 (4.76%) | 6 (12.50%) | |
| Left upper lobe, No. (%) | 10 (23.81%) | 10 (20.83%) | |
| Location of lesion (IQR), generation* | 6.60 (4–9) | 6.44 (5–9) | 0.50 |
| Lesion size (IQR), mm* | 22.19 (10.87–30.00) | 20.19 (7.54–29.94) | 0.15 |
| Radiographic lesion type | |||
| Solid | 32 (76.19%) | 33 (68.75%) | 0.13 |
| Subsolid | 10 (23.81%) | 15 (31.25%) | |
| RP-EBUS position | |||
| Within the lesion | 31 (73.81%) | 35 (72.92%) | 0.92 |
| Adjacent to the lesion | 11(26.19%) | 13 (27.08%) | |
| Distance to pleura (IQR), cm* | 10.50 (2.10–23.50) | 8.70 (0.08–17.55) | 0.28 |
| Time of planning pathway, min* | 9.79 (6.83–13.97) | 1.32 (0.50–2.55) | |
| Total operation time, min* | 28.02 (20.92–41.48) | 23.63 (5.48–24.55) | |
| Operating cost (RMB)* | 8229.44 ± 772.95 | 5041.97 ± 832.51 | |
*Values are mean ± SD, or median (range)
Total operation time = Time of planning pathway + Bronchoscopic procedural time
Operating cost includes basic bronchoscopy, anesthesia, RP-EBUS, biopsy forceps with or without VBN
HBN hand-drawn bronchoscopic navigation, VBN virtual bronchoscopic navigation, IQR interquartile range, RP-EBUS radial probe endobronchial ultra sonography
Fig. 4Flow chart of subject distribution and diagnosis. *Diagnosed by surgical resection or follow-up data. PPN peripheral pulmonary nodule, HBN hand-drawn bronchoscopic navigation, VBN virtual bronchoscopic navigation
Comparison of pathology and diagnostic efficacy between two groups
| Pathology | Etiology | VBN group | HBN group | |
|---|---|---|---|---|
| Diagnosed | Benign | Inflammation | 5 | 3 |
| Tuberculosis | 0 | 3 | ||
| Organizing pneumonia | 0 | 1 | ||
| Aspergillus | 0 | 1 | ||
| Granulomas | 5 | 3 | ||
| Adenocarcinoma | 12 | 19 | ||
| Squamous | 1 | 2 | ||
| small cell carcinoma | 2 | 1 | ||
| Undifferentiated carcinoma | 3 | 3 | ||
| Inflammation | 1 | 2 | ||
| Vasculitis | 1 | 1 | ||
| Organizing pneumonia | 2 | 0 | ||
| Tuberculosis | 2 | 0 | ||
| Cryptococcus | 0 | 1 | ||
| Pneumoconiosis | 0 | 1 | ||
| Sarcoidosis | 0 | 1 | ||
| Nocardia infection | 0 | 1 | ||
| Adenocarcinoma | 3 | 1 | ||
| Squamous | 0 | 2 | ||
| Undifferentiated carcinoma | 5 | 2 | ||
HBN hand-drawn bronchoscopic navigation, VBN virtual bronchoscopic navigation
Comparisons of lesion size, location and diagnostic yield
| VBN group | HBN group | ||
|---|---|---|---|
| Location, lobe | |||
| Right upper lobe | 5/10 (50.00%) | 8/10 (80.00%) | 0.35 |
| Right middle lobe | 8/10 (80.00%) | 3/4 (75.00%) | 0.56 |
| Right upper lobe | 7/10 (70.00%) | 12/18 (66.67%) | 1.00 |
| Left upper lobe | 2/2 (100.00%) | 5/6 (83.33%) | 1.00 |
| Left upper lobe | 6/10 (60.00%) | 7/10 (70.00%) | 1.00 |
| Radiographic lesion type | |||
| Solid | 20/32 (62.50%) | 23/33 (69.70%) | 0.61 |
| Subsolid | 6/10 (60.00%) | 12/15 (80.00%) | 0.28 |
| Benign lesions | |||
| < 20 mm | 4/8 (50.00%) | 6/11 (54.55%) | > 0.99 |
| > 20 mm to < 30 mm | 4/8 (50.00%) | 6/7 (85.71%) | 0.14 |
| Total | 8/16 (50.00%) | 12/18 (66.67%) | 0.49 |
| Malignant lesions | |||
| < 20 mm | 5/8 (62.50%) | 11/14 (78.57%) | 0.62 |
| > 20 mm to < 30 mm | 13/18 (72.22%) | 13/16 (81.25%) | 0.69 |
| Total | 18/26 (69.23%) | 24/30 (80.00%) | 0.35 |
| All lesions | |||
| < 20 mm | 9/16 (56.25%) | 17/25 (68.00%) | 0.52 |
| > 20 mm to < 30 mm | 17/26 (65.38%) | 19/23 (82.61%) | 0.21 |
| Total | 26/42 (61.90%) | 36/48 (75.00%) | 0.25 |
Data are shown as numbers of lesions with confirmed diagnosis/total lesions (%)
HBN hand-drawn bronchoscopic navigation, VBN virtual bronchoscopic navigation